Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Opportunities: Expanding Therapeutic Indications May Provide Future Growth Opportunities The huge potential for GLP-1 analogue drugs exists outside diabetes management
Zhou J, Montrose-Rafizadeh C, Janczewski AM, Pineyro MA, Sollott SJ, Wang Y, and Egan JM
This medication works by activating GLP-1 receptors in the body, which play a vital role in regulating appetite and glucose metabolism
By Application - Type 2 diabetes mellitus segment was valued at USD 23.54 billion in 2023 By Route of Administration - Subcutaneous injection segment accounted for the largest market revenue share in 2023 Market Size & Forecast Market Opportunities: USD 123.03 billion Market Future Opportunities: USD 100.08 billion CAGR from 2024 to 2029 : 25.3% Market Summary The GLP 1 analogues market is undergoing a significant transformation, driven by its expanding role in addressing interconnected metabolic diseases
US$ 29.10
US$ 27.86
US$ 23.68
US$ 28.46
